Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider Charmaine Gittleson acquired 1,666,666 shares of Percheron Therapeutics stock in a transaction on Tuesday, December 31st. The stock was purchased at an average price of A$0.01 ($0.01) per share, with a total value of A$14,999.99 ($9,316.77).
Percheron Therapeutics Stock Performance
About Percheron Therapeutics
Pernod Ricard SA produces and sells wines and spirits worldwide. It offers its products under various brands. The company was founded in 1805 and is headquartered in Paris, France.
Featured Stories
- Five stocks we like better than Percheron Therapeutics
- What is Forex and How Does it Work?
- 3 Legacy Tech Companies Reemerging as AI Leaders
- Which Wall Street Analysts are the Most Accurate?
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- What is a Bond Market Holiday? How to Invest and Trade
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
